|Articles|February 1, 2005
Gene delivery tested in mice holds promise for treating melanoma in humans
Tampa, Fla. — A novel gene therapy approach in mice is showing dramatic results in melanoma, but the technique has a long way to go if it is ever to demonstrate its effectiveness in humans.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Next-Generation IL-4Rα Targeting and Potential Dermatologic Implications
2
Off-Label Case Series: Topical Roflumilast for Mild HS
3
Recludix Pharma’s REX-8756 for Type 2 Inflammatory Diseases Enters First Human Trials
4
Comparative Analysis Positions Zasocitinib Among Next-Generation TYK2 Inhibitors
5














